| Ident. | Authors (with country if any) | Title |
|---|
| 000390 (2014) |
Erwan Bezard [République populaire de Chine] ; Elsa Y. Pioli ; Qin Li ; Françoise Girard ; Vincent Mutel ; Charlotte Keywood ; Francois Tison ; Olivier Rascol ; Sonia M. Poli | The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model. |
| 000408 (2014) |
J Mark Cooper [Royaume-Uni] ; Pb Oscar Wiklander [Suède] ; Joel Z. Nordin [Suède] ; Raya Al-Shawi [Royaume-Uni] ; Matthew J. Wood [Royaume-Uni] ; Mansi Vithlani [Royaume-Uni] ; Anthony H V. Schapira [Royaume-Uni] ; J Paul Simons [Royaume-Uni] ; Samir El-Andaloussi [Suède, Royaume-Uni] ; Lydia Alvarez-Erviti [Royaume-Uni] | Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice |
| 000453 (2014) |
Robert A. Hauser [États-Unis] ; Dee Silver ; Azhar Choudhry ; Eli Eyal ; Stuart Isaacson | Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease. |
| 000564 (2014) |
Julie C. Stout [Australie] ; Sarah Queller ; Kalyca N. Baker ; Sean Cowlishaw ; Cristina Sampaio ; Cheryl Fitzer-Attas ; Beth Borowsky | HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3. |
| 000601 (2014) |
Virginie Sattler [France] ; Maya Dickler ; Martin Michaud ; Sabine Meunier ; Marion Simonetta-Moreau | Does abnormal interhemispheric inhibition play a role in mirror dystonia? |
| 000699 (2013) |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins ; Kathryn A. Chung ; Robert A. Hauser ; Janis M. Miyasaki ; Anthony P. Nicholas ; Werner Poewe [Autriche] ; Klaus Seppi ; Olivier Rascol ; Mark A. Stacy ; John G. Nutt ; Caroline M. Tanner ; Alison Urkowitz ; Jean A. Jaglin ; Song Ge | Which dyskinesia scale best detects treatment response? |
| 000744 (2013) |
Stacey L. Kowal [États-Unis] ; Timothy M. Dall ; Ritashree Chakrabarti ; Michael V. Storm ; Anjali Jain | The current and projected economic burden of Parkinson's disease in the United States. |
| 000764 (2013) |
Chunyan Cao [République populaire de Chine] ; Yixin Pan ; Dianyou Li ; Shikun Zhan ; Jing Zhang ; Bomin Sun | Subthalamus deep brain stimulation for primary dystonia patients: a long-term follow-up study. |
| 000767 (2013) |
Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta | Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. |
| 000826 (2013) |
Leo P. Kelly [États-Unis] ; Paul M. Carvey [États-Unis] ; Ali Keshavarzian [États-Unis, Pays-Bas] ; Kathleen M. Shannon [États-Unis] ; Maliha Shaikh [États-Unis] ; Roy A. E. Bakay [États-Unis] ; Jeffrey H. Kordower [États-Unis] | Progression of Intestinal Permeability Changes and Alpha-Synuclein Expression in a Mouse Model of Parkinson’s Disease |
| 000827 (2013) |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon ; Amélie Pelletier ; Jacques Montplaisir | Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies. |
| 000904 (2013) |
Anthony E. Lang [Canada] ; Shirley Eberly ; Christopher G. Goetz ; Glenn Stebbins ; David Oakes ; Ken Marek ; Bernard Ravina ; Caroline M. Tanner ; Ira Shoulson | Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments. |
| 000909 (2013) |
Keith A. Josephs [États-Unis] ; Rong Xia ; Jay Mandrekar ; Jeffrey L. Gunter ; Matthew L. Senjem ; Clifford R. Jack ; Jennifer L. Whitwell | Modeling trajectories of regional volume loss in progressive supranuclear palsy. |
| 000925 (2013) |
Giulia Costa [Italie] ; Lucia Frau ; Jadwiga Wardas ; Annalisa Pinna ; Antonio Plumitallo ; Micaela Morelli | MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice. |
| 000930 (2013) |
G. Kranz [États-Unis, Autriche] ; E. A. Shamim [États-Unis] ; P. T. Lin [États-Unis] ; G. S. Kranz [Autriche] ; M. Hallett [États-Unis] | Long-term depression-like plasticity of the blink reflex for the treatment of blepharospasm |
| 000931 (2013) |
Stefanie Behnke [Allemagne] ; Anne Runkel ; Hadia Al-Sibai Kassar ; Mirjam Ortmann ; Daniel Guidez ; Ulrich Dillmann ; Klaus Fassbender ; Jörg Spiegel | Long-term course of substantia nigra hyperechogenicity in Parkinson's disease. |
| 000937 (2013) |
Maria Papathanou [Pays-Bas] ; Rika Van Der Laan ; Peter Jenner ; Sarah Rose ; Andrew C. Mccreary | Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats. |
| 000938 (2013) |
Jay S. Schneider [États-Unis] ; Elsa Y. Pioli ; Yang Jianzhong ; Qin Li ; Erwan Bezard | Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model. |
| 000943 (2013) |
Mirte J. Bakker [Pays-Bas] ; J Gert Van Dijk ; Astuti Pramono ; Sri Sutarni ; Marina A J. Tijssen | Latah: an Indonesian startle syndrome. |
| 000951 (2013) |
Raquel C R. Martinez [Brésil] ; Clement Hamani ; Milene Cristina De Carvalho ; Amanda Ribeiro De Oliveira ; Eduardo Alho ; Jessie Navarro ; Maria Gabriela Dos Santos Ghilardi ; Edson Bor-Seng-Shu ; Helmut Heinsen ; José Pinhata Otoch ; Marcus Lira Brandão ; Egberto Reis Barbosa ; Manoel Jacobsen Teixeira ; Erich Talamoni Fonoff | Intraoperative dopamine release during globus pallidus internus stimulation in Parkinson's disease. |
| 000956 (2013) |
Sharon L. Naismith [Australie] ; Loren Mowszowski ; Keri Diamond ; Simon J G. Lewis | Improving memory in Parkinson's disease: a healthy brain ageing cognitive training program. |
| 000959 (2013) |
Esther Cubo [Espagne] ; Miguel González ; Harvey Singer ; E Mark Mahone ; Lawrence Scahill ; Kirsten R. Müller-Vahl ; Raul De La Fuente-Fernández ; Diana Armesto ; Katie Kompoliti | Impact of placebo assignment in clinical trials of tic disorders. |
| 000992 (2013) |
C. Warren Olanow [États-Unis] ; Karl Kieburtz ; Olivier Rascol ; Werner Poewe [Autriche] ; Anthony H. Schapira ; Murat Emre ; Helena Nissinen ; Mika Leinonen ; Fabrizio Stocchi | Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease. |
| 000A33 (2013) |
Tuhin Virmani [États-Unis] ; Paul E. Greene ; Toni S. Pearson | Delayed onset of progressive chorea after acute basal ganglia injury. |
| 000B05 (2013) |
Scott J. Johnson [États-Unis] ; Melissa D. Diener ; Anna Kaltenboeck ; Howard G. Birnbaum ; Andrew D. Siderowf | An economic model of Parkinson's disease: implications for slowing progression in the United States. |
| 000B23 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia Trenkwalder | AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. |
| 000B40 (2013) |
Daniel M. Corcos [États-Unis] ; Julie A. Robichaud [États-Unis] ; Fabian J. David [États-Unis] ; Sue E. Leurgans [États-Unis] ; David E. Vaillancourt [États-Unis] ; Cynthia Poon [États-Unis] ; Miriam R. Rafferty [États-Unis] ; Wendy M. Kohrt [États-Unis] ; Cynthia L. Comella [États-Unis] | A Two Year Randomized Controlled Trial of Progressive Resistance Exercise for Parkinson’s Disease |
| 000B63 (2012) |
Katrina L. Paumier [États-Unis] ; Andrew D. Siderowf ; Peggy Auinger ; David Oakes ; Lalitha Madhavan ; Alberto J. Espay ; Fredy J. Revilla ; Timothy J. Collier | Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease. |
| 000B96 (2012) |
Diego García-Borreguero [Espagne] ; Birgit Högl ; Luigi Ferini-Strambi ; John Winkelman ; Christina Hill-Zabala ; Afsaneh Asgharian ; Richard Allen | Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks. |
| 000C08 (2012) |
Fritz Wodarg [Allemagne] ; Jan Herzog ; René Reese ; Daniela Falk ; Markus O. Pinsker ; Frank Steigerwald ; Olav Jansen ; Günther Deuschl ; H Maximillian Mehdorn ; Jens Volkmann | Stimulation site within the MRI-defined STN predicts postoperative motor outcome. |
| 000C25 (2012) |
Robert Chinnapongse [États-Unis] ; Kristen Gullo ; Paul Nemeth ; Yuxin Zhang ; Lynn Griggs | Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial. |
| 000C70 (2012) |
Frances M. Weaver [États-Unis] ; Kevin T. Stroupe ; Lishan Cao ; Robert G. Holloway ; Barbara G. Vickrey ; Tanya Simuni ; Ann Hendricks ; Dolores Ippolito | Parkinson's disease medication use and costs following deep brain stimulation. |
| 000D00 (2012) |
Anouk Van Der Hoorn ; At L. Hof ; Klaus L. Leenders ; Bauke M. De Jong | Narrowing wide-field optic flow affects treadmill gait in left-sided Parkinson's disease. |
| 000D22 (2012) |
Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro ; Paul Krack | Long-term outcomes of surgical therapies for Parkinson's disease. |
| 000D97 (2012) |
Cleide Lopes [Brésil] ; Andrea M. Esteves ; Roberto Frussa-Filho ; Sergio Tufik ; Marco Tulio De Mello | Evaluation of periodic limb movements in a putative animal model of restless leg syndrome. |
| 000D98 (2012) |
Caterina Mariotti [Italie] ; Roberto Fancellu ; Serena Caldarazzo ; Lorenzo Nanetti ; Daniela Di Bella ; Massimo Plumari ; Giuseppe Lauria ; Maria D. Cappellini ; Lorena Duca ; Alessandra Solari ; Franco Taroni | Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial. |
| 000E50 (2012) |
Norbert Kovács ; J Zsef Janszky ; Ferenc Nagy ; István Balás | Changing to interleaving stimulation might improve dystonia in cases not responding to pallidal stimulation. |
| 000F85 (2012) |
Harrison C. Walker [États-Unis] ; HE HUANG [États-Unis] ; Christopher L. Gonzalez [États-Unis] ; James E. Bryant [États-Unis] ; Jeffrey Killen [États-Unis] ; Gary R. Cutter [États-Unis] ; Robert C. Knowlton [États-Unis] ; Erwin B. Montgomery [États-Unis] ; Bart L. Guthrie [États-Unis] ; Ray L. Watts [États-Unis] | Short Latency Activation of Cortex During Clinically Effective Subthalamic Deep Brain Stimulation for Parkinson's Disease |
| 001278 (2011) |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Bichun Ouyang [États-Unis] | Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years |
| 001283 (2011) |
Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada] | Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia |
| 001285 (2011) |
Esther Cubo [Espagne] ; Sara Sáez Velasco [Espagne] ; Vanesa Delgado Benito [Espagne] ; Vanesa Ausín Villaverde [Espagne] ; Jose Maria Trejo Gabriel Y Galán [Espagne] ; Asuncion Martín Santidrián [Espagne] ; Jesús Macarr N Vicente [Espagne] ; José Cordero Guevara [Espagne] ; Elan D. Louis [États-Unis] ; Julian Benito-Le N [Espagne] | Validation of screening instruments for neuroepidemiological surveys of tic disorders |
| 001292 (2011) |
Karl Kieburtz [États-Unis] | Twice‐daily, low‐dose pramipexole in early Parkinson's disease: A randomized, placebo‐controlled trial |
| 001295 (2011) |
R. Hanajima [Japon] ; Y. Terao [Japon] ; S. Nakatani-Enomoto [Japon] ; S. Okabe [Japon] ; Y. Shirota [Japon] ; S. Oominami [Japon] ; H. Matsumoto [Japon] ; S. Tsuji [Japon] ; Y. Ugawa [Japon] | Triad stimulation frequency for cortical facilitation in cortical myoclonus |
| 001318 (2011) |
Alexandra Gaenslen [Allemagne] ; Irene Swid [Allemagne] ; Inga Liepelt-Scarfone [Allemagne] ; Jana Godau [Allemagne] ; Daniela Berg [Allemagne] | The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease |
| 001356 (2011) |
Lynn Rochester [Royaume-Uni] ; Katherine Baker [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; David Burn [Royaume-Uni] | Targeting dopa‐sensitive and dopa‐resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues |
| 001387 (2011) |
Christos Ganos [Allemagne] ; Alexander Münchau [Allemagne] ; Tobias B Umer [Allemagne] ; Christian Gerloff [Allemagne] ; Tim Magnus [Allemagne] | Seventy years of episodic stiffness: An unusual case of neuromyotonia |
| 001434 (2011) |
Catherine L. Gallagher [États-Unis] ; Terrence R. Oakes [États-Unis] ; Sterling C. Johnson [États-Unis] ; Moo K. Chung [États-Unis] ; James E. Holden [États-Unis] ; Barbara B. Bendlin [États-Unis] ; Donald G. Mclaren [États-Unis] ; Guofan Xu [États-Unis] ; Robert J. Nickles [États-Unis] ; Robert Pyzalski [États-Unis] ; Onofre Dejesus [États-Unis] ; W. Douglas Brown [États-Unis] | Rate of 6‐[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease |
| 001459 (2011) |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
| 001491 (2011) |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
| 001578 (2011) |
Peggy Reiner [France] ; Damien Galanaud [France] ; Gaëlle Leroux [France] ; Marie Vidailhet [France] ; Julien Haroche [France] ; Du Le Thi Huong [France] ; Camille Francès [France] ; Thomas Papo [France] ; Christian De Gennes [France] ; Lucile Musset [France] ; Bertrand Wechsler [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Nathalie Costedoat-Chalumeau [France] | Long‐term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies |
| 001579 (2011) |
Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; María Jose Blanco-Prieto [Espagne] ; María S. Aymerich [Espagne] | Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease |
